drugset / Trial / NCT01121081

The Effect of Algae Dunaliella Bardawil on Psoriasis (2)

NCT01121081 ↗

Phase 3 Withdrawn Sheba Medical Center
RandomizedParallel-groupDouble-blindTreatment

Summary

This is a Randomized, Double-Blind, , Placebo Controlled, 18 Week Study To Evaluate the Efficacy of adjuvant 9-cis-β-Carotene Rich powder of the Alga Dunaliella bardawil in Subjects With Plaque type Psoriasis treated by Narrow Band UVB therapy.

Timeline

Start
2010-01
Primary completion
2011-01
Completion
2012-01

Outcome

Outcome not reported

Stopped (Enrollment): “no patients enrolled”

Drugs

EvaluationDrugModalityDoseRoute
Subject Alga Dunaliella Bardawil Unknown — Oral

Indications